Anika Therapeutics (ANIK) Construction in Progress (2011 - 2016)

Anika Therapeutics (ANIK) has reported Construction in Progress for 6 consecutive years, with $22.7 million the latest figure, recorded in Q4 2016.

• On a quarterly basis, Construction in Progress rose 101.3% year-over-year to $22.7 million in Q4 2016; TTM through Dec 2016 was $22.7 million, a 101.3% increase from a year earlier, with the FY2016 full-year figure at $22.7 million, up 101.3% from the prior year.
• Construction in Progress was $22.7 million for Q4 2016 at Anika Therapeutics, up from $11.3 million in the prior quarter.
• Over five years, Construction in Progress peaked at $22.7 million in Q4 2016 and troughed at $42270.0 in Q4 2012.
• A 5-year average of $6.9 million and a median of $559000.0 in 2014 frame the typical range for Construction in Progress.
• Across the five-year window, Construction in Progress sank 99.84% in 2012 and soared 1916.82% in 2015, its largest moves.
• Over 5 years, Construction in Progress stood at $42270.0 in 2012, then surged by 272.11% to $157292.0 in 2013, then jumped by 255.39% to $559000.0 in 2014, then soared by 1916.82% to $11.3 million in 2015, then surged by 101.3% to $22.7 million in 2016.
• The last three Construction in Progress figures came in at $22.7 million (Q4 2016), $11.3 million (Q4 2015), and $559000.0 (Q4 2014), per Business Quant data.